Explore the categories so you can find more about your search.

Categorie > Huntingtons Disease

New Agent Found To Fight Genetic Disorders - Zorro-Locked Nucleic Acid

Categorie : Huntingtons Disease
A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called "Zorro-LNA," which has the potential to stop genetic disorders in their tracks. In the study, researchers from the Karolinska Institute in Stockholm, Sweden, describe how they developed Zorro-LNA to b ...

read more A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called read more Sun Oct 2007 Sun Oct 2007

As Huntington's Disease Awareness Month Commences, A New Drug Offers Hope To Pre-Symptomatic Sufferers

Categorie : Huntingtons Disease
With May's Huntington's Disease Awareness Month as a backdrop, the Avicena Group, a California based biotech company, is set to launch a clinical trial for a new drug therapy, HD-02, with the ultimate aim of delaying the onset of this incurable, fatal disease. If successful, this compound would ...

read more With May's Huntington's Disease Awareness Month as a backdrop, the Avicena Group, a California based biotech company, is set to launch a clinical trial for a new drug therapy, HD-02, with the ultimate aim of delaying the onset of this incurable, fatal disease. If successful, this compound would read more Sun Oct 2007 Sun Oct 2007

Avicena To Advance Huntington's Disease Clinical Program Into Phase III

Categorie : Huntingtons Disease
Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease. Th ...

read more Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases, announced today the selection of the optimal dose of HD-02, its novel drug candidate for the treatment of Huntington's Disease. Th read more Sun Oct 2007 Sun Oct 2007

Medicine To Alleviate Huntington's?

Categorie : Huntingtons Disease
Huntington's disease is a hereditary disorder that primarily affects the brain, leading to death within just over a decade. There is no treatment for the disease at present, but researchers at Lund University in Sweden believe that a medicine used for Alzheimer's disease could alleviate some of the ...

read more Huntington's disease is a hereditary disorder that primarily affects the brain, leading to death within just over a decade. There is no treatment for the disease at present, but researchers at Lund University in Sweden believe that a medicine used for Alzheimer's disease could alleviate some of the read more Sun Oct 2007 Sun Oct 2007

Avicena To Present Its Huntington's Disease Clinical Program At The Huntington's Disease Of America Society 22nd Annual Convention

Categorie : Huntingtons Disease
Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company focused on commercializing its proprietary cellular energy modulation technology, announced today its participation at the Huntington's Disease of America Society's 22nd Annual Convention, which will take place June 1 ...

read more Avicena Group, Inc. (OTC Bulletin Board: AVGO), a late stage biotechnology company focused on commercializing its proprietary cellular energy modulation technology, announced today its participation at the Huntington's Disease of America Society's 22nd Annual Convention, which will take place June 1 read more Sun Oct 2007 Sun Oct 2007

Britain To Go Ahead With Human-Animal Embryos For Research

Categorie : Huntingtons Disease
The British government published its draft bill to overhaul the 1990 Human Fertilisation and Embryology Act this week and it differs from the White Paper introduced late last year in that research using part human part animal embryos is to be allowed after all. [click link for full article] ...

read more The British government published its draft bill to overhaul the 1990 Human Fertilisation and Embryology Act this week and it differs from the White Paper introduced late last year in that research using part human part animal embryos is to be allowed after all. [click link for full article] read more Sun Oct 2007 Sun Oct 2007

Breakthrough In Huntington's Research

Categorie : Huntingtons Disease
A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds.Researchers in the University's Faculty of Biological Sciences have discovered that one of the body's naturally occurring proteins is preventing 57 genes f ...

read more A major breakthrough in the understanding and potential treatment of Huntington's disease has been made by scientists at the University of Leeds.Researchers in the University's Faculty of Biological Sciences have discovered that one of the body's naturally occurring proteins is preventing 57 genes f read more Sun Oct 2007 Sun Oct 2007

New Drug Target For Huntington's Disease

Categorie : Huntingtons Disease
McMaster University researchers have first insight into how Huntington's disease (HD) is triggered. The research is published online in the British Journal, Human Molecular Genetics."These are exciting results by the McMaster team," said Dr. Rémi Quirion, Scientific Director at the Canadi ...

read more McMaster University researchers have first insight into how Huntington's disease (HD) is triggered. The research is published online in the British Journal, Human Molecular Genetics. read more Sun Oct 2007 Sun Oct 2007

Alnylam And Medtronic Advance Collaboration On Drug-Device Combinations With RNAi Therapeutics For CNS Diseases

Categorie : Huntingtons Disease
Medtronic, Inc., (NYSE: MDT) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced that the companies are advancing their collaboration initiated in February, 2005, following positive pre-clinical data generated under the initial joint technology develo ...

read more Medtronic, Inc., (NYSE: MDT) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced that the companies are advancing their collaboration initiated in February, 2005, following positive pre-clinical data generated under the initial joint technology develo read more Sun Oct 2007 Sun Oct 2007

Animal Models Of Huntington's Disease On Target

Categorie : Huntingtons Disease
An international team of researchers has published a benchmark study showing that gene expression in several animal models of Huntington's Disease (HD) closely resembles that of human HD patients.The results, published August 1, 2007, in the journal Human Molecular Genetics, validate the applicabili ...

read more An international team of researchers has published a benchmark study showing that gene expression in several animal models of Huntington's Disease (HD) closely resembles that of human HD patients.The results, published August 1, 2007, in the journal Human Molecular Genetics, validate the applicabili read more Sun Oct 2007 Sun Oct 2007

Medivation Announces Treatment Of First Patient In Phase 2 Trial Of Dimebon(TM) In Huntington's Disease

Categorie : Huntingtons Disease
Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in its Phase 2 trial of Dimebon(TM) to treat Huntington's disease. Medivation has expanded patient enrollment in the trial by 20 percent -- to 90 patients -- in order to enhance the ability to detect dif ...

read more Medivation, Inc. (Nasdaq: MDVN) today announced treatment of the first patient in its Phase 2 trial of Dimebon(TM) to treat Huntington's disease. Medivation has expanded patient enrollment in the trial by 20 percent -- to 90 patients -- in order to enhance the ability to detect dif read more Sun Oct 2007 Sun Oct 2007

Drug Protects Brain Cells In Huntington's Disease Model

Categorie : Huntingtons Disease
A drug used in some countries to treat the symptoms of Huntington's disease prevents death of brain cells in mice genetically engineered to mimic the hereditary condition, UT Southwestern Medical Center researchers have found. The research sheds light on the biochemical mechanisms involved in the di ...

read more A drug used in some countries to treat the symptoms of Huntington's disease prevents death of brain cells in mice genetically engineered to mimic the hereditary condition, UT Southwestern Medical Center researchers have found. The research sheds light on the biochemical mechanisms involved in the di read more Sun Oct 2007 Sun Oct 2007

Huntington's Disease Sufferers Need Focussed Management Of Sleep Symptoms In Their Treatment

Categorie : Huntingtons Disease
Mice carrying the genetic mutation that causes Huntington's Disease (HD) showed marked improvements in alertness and their ability to learn after they were given drugs that put them to sleep.Researchers at the University of Cambridge found that daily treatments of Alprazolam or chloral hydrate, two ...

read more Mice carrying the genetic mutation that causes Huntington's Disease (HD) showed marked improvements in alertness and their ability to learn after they were given drugs that put them to sleep.Researchers at the University of Cambridge found that daily treatments of Alprazolam or chloral hydrate, two read more Sun Oct 2007 Sun Oct 2007

CombinatoRx Receives Huntington's Disease Society Leadership Award

Categorie : Huntingtons Disease
CombinatoRx, Incorporated (NASDAQ: CRXX) announced that it has received the Marjorie Guthrie Leadership Award from the Huntington's Disease Society of America (HDSA) during their 40th Anniversary Guthrie Awards Dinner in New York City to benefit the Woody and Marjorie Guthrie Research fund. Alexis B ...

read more CombinatoRx, Incorporated (NASDAQ: CRXX) announced that it has received the Marjorie Guthrie Leadership Award from the Huntington's Disease Society of America (HDSA) during their 40th Anniversary Guthrie Awards Dinner in New York City to benefit the Woody and Marjorie Guthrie Research fund. Alexis B read more Sun Oct 2007 Sun Oct 2007

Animal Study Identifies Potential Treatment For Huntington's Disease

Categorie : Huntingtons Disease
MassGeneral Institute for Neurodegererative Disease (MIND) researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington's Disease (HD). Their report, which will appear in the Proceedings of the National Academy of Sciences, describes how a ...

read more MassGeneral Institute for Neurodegererative Disease (MIND) researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington's Disease (HD). Their report, which will appear in the Proceedings of the National Academy of Sciences, describes how a read more Sun Oct 2007 Sun Oct 2007

Potential Treatment For Huntington's Disease Identified

Categorie : Huntingtons Disease
MassGeneral Institute for Neurodegererative Disorders (MIND) researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington's Disease (HD). Their report, which will appear in the Proceedings of the National Academy of Sciences, describes how ...

read more MassGeneral Institute for Neurodegererative Disorders (MIND) researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington's Disease (HD). Their report, which will appear in the Proceedings of the National Academy of Sciences, describes how read more Sun Oct 2007 Sun Oct 2007

New Avenue Of Research Against Huntington's Disease

Categorie : Huntingtons Disease
Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease -- a fatal disorder for which there is currently no cure or even a treatment to slow the disease.In a paper published in the Journal of Clinical Investiga ...

read more Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease -- a fatal disorder for which there is currently no cure or even a treatment to slow the disease.In a paper published in the Journal of Clinical Investiga read more Sun Oct 2007 Sun Oct 2007

Britain To Go Ahead With Human-Animal Embryos For Research

Categorie : Huntingtons Disease
The British government published its draft bill to overhaul the 1990 Human Fertilisation and Embryology Act this week and it differs from the White Paper introduced late last year in that research using part human part animal embryos is to be allowed after all. [click link for full article] ...

read more The British government published its draft bill to overhaul the 1990 Human Fertilisation and Embryology Act this week and it differs from the White Paper introduced late last year in that research using part human part animal embryos is to be allowed after all. [click link for full article] read more Fri May 2007 Fri May 2007

Subtle Signs Can Help Predict Huntington's Disease Early

Categorie : Huntingtons Disease
Subtle signs can help doctors predict that a person will develop Huntington's disease in the next few years, according to a study published in the May 15, 2007, issue of Neurology®, the scientific journal of the American Academy of Neurology. Huntington's disease is a genetic disorder that affects m ...

read more Subtle signs can help doctors predict that a person will develop Huntington's disease in the next few years, according to a study published in the May 15, 2007, issue of Neurology®, the scientific journal of the American Academy of Neurology. Huntington's disease is a genetic disorder that affects m read more Wed May 2007 Wed May 2007

As Huntington's Disease Awareness Month Commences, A New Drug Offers Hope To Pre-Symptomatic Sufferers

Categorie : Huntingtons Disease
With May's Huntington's Disease Awareness Month as a backdrop, the Avicena Group, a California based biotech company, is set to launch a clinical trial for a new drug therapy, HD-02, with the ultimate aim of delaying the onset of this incurable, fatal disease. If successful, this compound would sig ...

read more With May's Huntington's Disease Awareness Month as a backdrop, the Avicena Group, a California based biotech company, is set to launch a clinical trial for a new drug therapy, HD-02, with the ultimate aim of delaying the onset of this incurable, fatal disease. If successful, this compound would sig read more Thu May 2007 Thu May 2007

1 | 2 | 3 next >>>



     


Custom Search